Healthcare

Healius Limited provides medical laboratory testing and pathology services across Australia through a network of laboratories and specimen collection centres. Following its FY26 results and October annual general meeting, attention remains on pathology operating margins, cost management and changes to the group’s business portfolio. …

AVITA Medical (ASX:AVH) develops and markets therapeutic products for acute wound care, including its RECELL platform and complementary technologies used in the management of burns and complex wounds. On 26 October 2026, AVITA Medical (ASX:AVH) was quoted at AUD 4.29, down 0.69% for the …

The webinar will take place at 11am AEDT on Monday, 2 November 2026, and will be hosted by Dr Julian Chick, Chief Executive Officer and Managing Director. Registration is available through the company's Zoom link, and a replay will be available at the same …

The FDA accepted AdAlta's pre-IND meeting request in September 2026, with the meeting scheduled for 3 November 2026 US time. Written minutes are usually issued two to four weeks after the meeting. The briefing pack was approved by the EW-001 Joint Development Committee and …

INVEX plans to issue up to 45,000,000 fully paid ordinary shares at an estimated A$0.08 per share. The company also proposes to issue 91,250,000 performance rights, comprising 22,812,500 Class A rights expiring on 15 December 2030, 45,625,000 Class B rights expiring on 15 June …

Artrya Limited (ASX:AYA), a medical technology company commercialising its Salix AI-powered cloud platform for coronary artery disease, released its Appendix 4C and activities report for the quarter ended 30 September 2026 on 26 October 2026.

Biome Australia Limited (ASX:BIO) released its Appendix 4C and activity report for the quarter ended 30 September 2026 (Q1 FY27) on 26 October 2026, covering pharmacy sales, manufacturing, China distribution and clinical trial recruitment.